Clin Osteol 2007; 12(4): 148-150

Effect of vitamin A on bone metabolismCase reports

I. Raška, O. Raška, P. Broulík

Vitamin A is a generic term for a large group of chemically related substances exhibiting retinoid activity. In the human organism, they participate in the regulation of many essential functions. The most important retinoid is apparently retinoic acid synthesized from vitamin A in essentially all cell types including osteoblasts, osteoclasts and chondrocytes. Through retinoic acid receptors, retinoids play a major role in regulating gene expression, inhibition of cell proliferation, differentiation and apoptosis. Lack of vitamin A leads to congenital malformations of the eye, heart, gonads and lungs. The short communication deals with the effects of vitamin A and its metabolites on bone metabolism and development of osteoporosis. The results of clinical studies concerning these issues are not always explicit. However, most of them suggest that administration of vitamin A contributes to osteoporosis, which is consistent with our fin­ dings. At present, the results of experimental studies designed to clarify the molecular basis for the effect of retinoic acid on the bone do not allow to provide comprehensive information about the involved mechanisms. In this respect, of particular interest is the recent finding mentioned in the text suggesting that retinoic acid may affect the cell metabolism in two completely different ways, either through the retinoic acid receptor or through the PPAR p/8 nuclear receptor. Activation of the RAR produces the arrest of cellular growth, apoptosis and signs of antitumour activity, whereas activation of the PPAR p/8 potentiates cell survival, proliferation and pro­ motes tumour growth.

Keywords: vitamin A, retinoids, nuclear receptors RAR a PPAR p/8, bone metabolism, osteoporosis

Published: December 11, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Raška I, Raška O, Broulík P. Effect of vitamin A on bone metabolism. Osteologický bulletin. 2007;12(4):148-150.
Download citation

References

  1. Barker ME et Blumsohn A. Is vitamin A consumption a risk factor for osteoporo­ tic fracture? Proc Nutr Soc. 2003;Nov;62(4):845-50. Review. Go to original source...
  2. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H. LX. Retinoic acid receptors. Pharma­ col Rev. 2006;58(4):712-725. Go to original source...
  3. Michalik L et Wahli W. Guiding ligands to nuclear receptors. Cell. 2007,18; 129(4):649-51. Review. Go to original source...
  4. Mark M, Ghyselinck NB, Chambon P. Function of retinoid nuclear receptors: les­ sons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol. 2006;46: 451-80. Review. Go to original source...
  5. Garratini E, Gianni M, Terao M. Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations. Curr Pharm Des. 2007;I3(I3):I375 400. Review Go to original source...
  6. Raška I Jr et Broulík P. The impact of diabetes mellitus on skeletal health: an es­ tablished phenomenon with inestablished causes? Prague Med Rep. 2005;106(2): 137-48. Review.
  7. Broulík P, Poruchy kalciofosfátového metabolismu, První vydání, Praha, Grada Publishing 2003.
  8. Michaelsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med. 2003;23;348(4):287-94. Go to original source...
  9. Promislow JHE, Goodman-Gruen D, Slymen DJ & Barrett-Connor E. Retinol in­ take and bone mineral density in the elderly: the Raneho Bernardo Study. J Bone Miner Res 2002;17 1349-1358. Go to original source...
  10. Feskanich D, Singh V, Willett WC, Colditz GA Vitamin A intake and hip fractu­ res among postmenopausal women. JAMA, 2002;2;287(1):47-54. Go to original source...
  11. Rohde CM, DeLuca H. Bone resorption activity of all-trans retinoic acid is inde­ pendent of vitamin D in rats. J Nutr. 2003;Mar;133(3):777-83. Go to original source...
  12. Johansson S, Melhus H. Vitamin A antagonizes calcium response to vitamin D in man. J Bone Miner Res. 2001;16(10):1899-905. Go to original source...
  13. Genaro Pde S, Martini LA. Vitamin A supplementation and risk of skeletal frac­ ture. Nutr Rev. 2004;62(2):65-7. Review. Go to original source...
  14. Barker ME, McCloskey E, Saha S, Gossiel F, Charlesworth D, Powers HJ, Blum­ sohn A. Serum retinoids and beta-carotene as predictors of hip and other fractures in elderly women. J Bone Miner Res. 2005;20(6):913-20. Go to original source...
  15. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature. 2003;15;423(6937):349-55. Review. Go to original source...
  16. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;15;423(6937):337^2. Review. Go to original source...
  17. Hotchkiss CE, Latendresse J, Ferguson SA. Oral treatment with retinoic acid decreases bone mass in rats. Comp Med. 2006;56(6):502-11.
  18. van Beek E, Lowik C, Karperien M, Papapoulos S. Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosyn­ thetic pathway: the role of the retinoic acid receptor. Bone. 2006;38(2):167-71. Go to original source...
  19. Yonezawa T, Hasegawa S, Ahn JY, Cha BY, Teruya T, Hagiwara H, Nagai K, Woo JT. Tributyltin and triphenyltin inhibit osteoclast differentiation through a retinoic acid receptor-dependent signaling pathway. Biochem Biophys Res Commun. 2007;30;355(1):10-5. Go to original source...
  20. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N.Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear recep­ tors. Cell. 2007;18;129(4):723-33. Práce vznikla za podpory VZ MŠMT 0021620816. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.